FibroScan®
Webinar | 02.04.2023
Blog y noticias
topic :
category :
estado :
Comunicado de prensa | 02.04.2023
Echosens y Novo Nordisk anuncian una asociación para aumentar la concienciación y avanzar en el diagnóstico precoz de la EHNA
Webinar | 24.05.2023
Improving Management of Patients with Advanced Liver Disease Through Liver and Spleen Stiffness Assessment
Webinar | 02.04.2023
Current Perspectives in NAFLD-NASH Identification & Management – A Diabetologist’s Perspective
Comunicado de prensa | 02.04.2023
Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary
Artículo | 02.04.2023
Liver Health Experts and Echosens Technology Featured on eHealth Radio Network
Webinar | 02.04.2023
AASLD Wrap Up; Key Lessons in NAFLD NASH Diagnostic Strategies
Artículo | 02.04.2023
Highlights from 2021 AASLD Liver Meeting: Early Detection and Monitoring with FibroScan® Mitigates Risk of Patients Developing Fibrosis/Cirrhosis
Artículo | 02.04.2023
Non-Invasive Point-of-Care Exam Helps Battle Liver Disease in Individuals with Obesity
Artículo | 02.04.2023
Link Between Non-alcoholic Fatty Liver Disease, Obesity and Liver Cancer Calls for Early Detection and Monitoring
Artículo | 02.04.2023
New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan® and Care Management
Comunicado de prensa | 02.04.2023
Echosens Highlights New EASL Clinical Practice Guidelines
Artículo | 02.04.2023
Douglas Dieterich, M.D., discusses role of FibroScan® in the diagnoses of chronic liver disease
Artículo | 02.04.2023
Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus
Artículo | 02.04.2023